Trademark owner · USPTO register · rebuilt nightly

Roche Molecular Systems, Inc.

98 live US trademarks, filing since 1988. 2 new applications filed this year.

Live marks
98
registered + pending
Registered
72
on the Principal Register
Pending
26
applications in progress
Filed in 2026
2
by filing date
Classes used
6
of 45 Nice classes
First filing
1988
38 years on the register
At a glanceplain-language reads of the register
Mostly chemicals: 42 of 98 live marks are in Class 1. Electronics & software (Class 9) is next with 29.
8 registrations have a maintenance filing due in the next 12 months, 1 already in the grace period.
Filing activityapplications per year, by filing date
0 15 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Roche Molecular Systems, Inc. filed most recently.

MarkClassFiledBasisStatusSerial
AVENIO 10 Apr 24, 2026 — pending 99784855
AVENIO 5 Apr 24, 2026 — pending 99784898
PATHASSIST DERM 42 Dec 12, 2025 in use registered Sep 15 99545460
IHCEXPLORE 9, 42, 44 Dec 12, 2025 in use registered Sep 15 99545486
AXELIOS 1, 9 May 9, 2025 in use registered Oct 20 99177462
AXELIOS 5, 10 May 9, 2025 — published 99177562
KAPA EVOAMP 1 Mar 11, 2025 — published 99077404
AXELIOS 1, 9 Jul 23, 2024 — registered Sep 22 98661935
AXELIOS 5, 10 Jul 23, 2024 — published 98661958
XILITY 1, 9, 42 Jul 23, 2024 — published 98661977
Recently registeredlast 12 months
AXELIOS · Cl. 1, 9 · Reg. 8,515,336
Oct 20, 2026
AXELIOS · Cl. 1, 9 · Reg. 8,451,641
Sep 22, 2026
PATHASSIST DERM · Cl. 42 · Reg. 8,431,108
Sep 15, 2026
IHCEXPLORE · Cl. 9, 42, 44 · Reg. 8,431,111
Sep 15, 2026

Registration starts the maintenance clock: a Section 8 declaration is due between years 5 and 6.

Maintenance windows aheadnext 12 months · from registration dates
HYPERCAPTURE · Reg. 6,113,889 · registered Jul 2020
Section 8 declaration (years 5–6) · in grace period until Jan 28, 2027
Jul 28, 2025 → Jul 28, 2026
GASTROCOR · Reg. 3,180,365 · registered Dec 2006
Section 8 & 9 renewal (year 20)
Dec 5, 2025 → Dec 5, 2026
GYNECOR · Reg. 3,180,366 · registered Dec 2006
Section 8 & 9 renewal (year 20)
Dec 5, 2025 → Dec 5, 2026
CYTOLOGYPRO XT · Reg. 5,100,009 · registered Dec 2016
Section 8 & 9 renewal (year 10)
Dec 13, 2025 → Dec 13, 2026
EVOSCRIPT · Reg. 5,125,375 · registered Jan 2017
Section 8 & 9 renewal (year 10)
Jan 17, 2026 → Jan 17, 2027
BOSTWICK LABORATORIES · Reg. 3,205,211 · registered Feb 2007
Section 8 & 9 renewal (year 20)
Feb 6, 2026 → Feb 6, 2027
BOSTWICK LABORATORIES · Reg. 3,205,212 · registered Feb 2007
Section 8 & 9 renewal (year 20)
Feb 6, 2026 → Feb 6, 2027
KAPA · Reg. 5,217,034 · registered Jun 2017
Section 8 & 9 renewal (year 10)
Jun 6, 2026 → Jun 6, 2027

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Other large filers in Class 1Full ranking →
Names on the registerwhat this page merges, and what it leaves out
ROCHE MOLECULAR SYSTEMS, INC. · 98 live marks
included
Roche Diagnostics Gmbh · 165 live marks · may be a related company
separate page
Roche Diagnostics Operations, Inc. · 79 live marks · may be a related company
separate page
Roche Diabetes Care Gmbh · 59 live marks · may be a related company
separate page
Roche Bros. Midco, LLC · 10 live marks · may be a related company
separate page

Spellings are merged when they differ only in punctuation or legal suffix. Anything else stays separate rather than guessed.

Common questions

About Roche Molecular Systems, Inc. trademarks.

How many trademarks does Roche Molecular Systems, Inc. have?

98 live US trademarks as of October 23, 2026: 72 registered and 26 pending applications. 2 were filed in 2026 so far.

What does Roche Molecular Systems, Inc. sell, according to its trademarks?

Mostly chemicals (Class 1, 42 live marks). Also electronics & software (Class 9) and pharmaceuticals (Class 5).

Who owns the AMPLITAQ trademark?

AMPLITAQ is owned by Roche Molecular Systems, Inc.. It was registered on November 14, 1989 (Reg. No. 1565315) and is live. The same owner holds 97 other live US marks.

When did Roche Molecular Systems, Inc. first file a trademark?

Its oldest live US filing dates from 1988: AMPLITAQ, filed September 30, 1988.

Know the morning after Roche Molecular Systems, Inc. files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.